| Literature DB >> 20214810 |
Charu G Kumar1, Robin E Everts, Juan J Loor, Harris A Lewin.
Abstract
BACKGROUND: The diversity of placental architectures within and among mammalian orders is believed to be the result of adaptive evolution. Although, the genetic basis for these differences is unknown, some may arise from rapidly diverging and lineage-specific genes. Previously, we identified 91 novel lineage-specific transcripts (LSTs) from a cow term-placenta cDNA library, which are excellent candidates for adaptive placental functions acquired by the ruminant lineage. The aim of the present study was to infer functions of previously uncharacterized lineage-specific genes (LSGs) using co-expression, promoter, pathway and network analysis.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20214810 PMCID: PMC2848242 DOI: 10.1186/1471-2164-11-161
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Schema for inferring functions of LSGs.
Figure 2Co-expression of LSTs and other genes in LIVR cluster. The cluster of 212 genes (LIVR) shows a significant (P < 0.0001) difference in expression (~1.8-fold) between ad-libitum (AD; left panel) and energy-restricted (RS; right panel) diets at +1 and +14 days post-partum.
Figure 3Co-expression of genes in PLAC and THYM clusters. The average pairwise Pearson correlation (r) within each cluster was r ≥ 0.75. The correlation between any one of the LSTs and any known gene was r ≥ 0.90: A) Co-expression of LSTs 22JE, 34FL, and 104JE with 113 other genes using expression data from 18 cattle tissues. A cluster of 116 genes (PLAC) shows preferential expression in placentome, with each gene having ≥ 2-fold higher expression in placentome as compared to any other tissue: B) Co-expression of LSTs 383NG and 21PW with 30 other genes using expression data from 18 cattle tissues. A cluster of 32 genes (THYM) shows preferential expression in thymus with each gene having ≥ 2 fold higher expression in thymus as compared to any other tissue. L_Intestine, large intestine; M_L_Node, mesenteric lymph node; S_Intestine, small intestine.
Figure 4Clustering of 28 LSTs significantly expressed (P < 0.05) at one or more time-point(s) and by diet. Gray cells indicate that the gene is either not expressed at that time-point/diet, had missing data, or did not meet the filtering criteria (see Methods). The numbers at the intersection of branches indicate the branch-correlation. Green cells indicate under-expression, orange/red/pink cells indicate over-expression, and yellow cells indicate no change in expression compared to the reference sample.
Summary information for nine LSTs co-expressed with known genes.
| LST | Btau_3.1 | Length (LST) | Exon | ||||
|---|---|---|---|---|---|---|---|
| 22JE | PLAC | chr7:65,670,509-65,672,078 | 1569 | 1 | ncRNA | Bt, Ss | |
| 104JE | PLAC | chr3:78,876,417-78,886,469 | 619 | 5 | 68 | Bt, Ss, Oa | |
| 34FL | PLAC | chr29:24532031-24538612 | 1571 | 2 | 100Kc | Bt, Ss, Oa, Ch, Ec, | |
| 383NG | THYM | chr8:31,549,088-31,549,951 | 864 | 1 | 61Kc | Bt, Oa | |
| 21PW | THYM | chr26:12,357,963-12,358,929 | 977 | 1 | 67 | Bt | |
| 5BP | LIVR | chr3:92,641,001-92,641,610 | 610 | 1 | ncRNA | Bt | |
| 237NG | LIVR | chr19:51,623,121-51,623,742 | 622 | 1 | 62 | Bt | |
| 39NG | LIVR | chr3:79,052,419-79,054,067 | 767 | 2 | 172Kc | Bt | |
| 266NG | LIVR | chr12:29,282,078-29,283,427 | 783 | 2 | 38Kc | Bt |
a PLAC, placenta; THYM, thymus; LIVR, liver
b A CDS, length of coding sequence in amino acids.
c A Kozak consensus sequence is predicted at the beginning of the ORF.
d Bt, Bos taurus (cattle); Ss, Sus scrofa (pig); Oa, Ovis aries (sheep); Ch, Capra hircus (goat); Ec, Equus caballus (horse).
Over-represented ordered TFBS pairs and unordered TFBS triplets in LIVR, PLAC and THYM co-expression clusters.
| Cluster | P-value | ||||
|---|---|---|---|---|---|
| LIVR | Oct-1b | 0.002 | 0.152 | [ | NAe |
| p53 | 0.002 | 0.152 | [ | NA | |
| Sp1*Pax-8 | 0.001 | 0.049 | [ | Agrin in postsynaptic differentiation; | |
| SREBP-1*Pax-8b | 0.002 | 0.049 | [ | glycerophospholipid metabolism; | |
| ZF5*YY1 | 0.002 | 0.049 | [ | Wnt signaling pathway; | |
| Ebox*c-Ets-1(p54) | 0.004 | 0.052 | [ | nicotinate and nicotinamide | |
| AP-2, ZF5, c-Ets | 0.027 | 0.026 | [ | adipocytokine signaling pathway; | |
| PLAC | STAT*Pax-2b | 0.0009 | 0.10 | [ | glycerolipid metabolism (with STAT |
| Tax/CREB*ETF | 10-05 | 0.039 | NA | EGFR-specific transcription factor | |
| Oct-1*GATA-4 | 0.0009 | 0.10 | [ | mod003360; mod065501; mod070287 | |
| Tel-2*VDR | 0.0005 | 0.10 | NA | Phosphatidylinositol signaling system; | |
| THYM | v-Mybb | 10-05 | 0.069 | [ | NA |
| KROX | 0.004 | 0.224 | [ | NA | |
| Nkx2-5*CdxAb | 0.0006 | 0.077 | [ | N-glycan biosynthesis; ribosome; | |
| MAF*HOXA7 | 0.0002 | 0.077 | NA | phospholipase C-epsilon pathway |
a * indicates order in this composite; ',' within the TFBS composite indicates an unordered composite.
b Indicates that this composite is also predicted in an LST.
c FDR corrected P-value
d mod#, PREMOD identifier representing a predicted TFBS module.
e NA, not applicable.
Ingenuity Pathway Analysis of gene clusters.
| Genes included in the function | ||
|---|---|---|
| LIVR (143/212) | glycerophospholipid metabolism (C) | |
| cancer (F) | ||
| repair of DNA (F) | ||
| immune response of organism (F) | ||
| development of epidermis (F) | ||
| PLAC (64/116) | Wnt/beta-catenin signaling (C) | |
| acute-phase response signaling(C) | ||
| tissue morphology--size (F) | ||
| small molecule biochemistry- transport of amino acids and synthesis of prostaglandin (F) | ||
| embryonic development-- proliferation and formation of embryonic tissue (F) | ||
| development of embryonic and trophoblast cells (F) | ||
| cell cycle--entry into cell stage (F) | ||
| lipid Metabolism | ||
| cell adhesion (F) | ||
| transcription (F) | ||
| cancer--cell death of tumor cell lines(F) | ||
| THYM (18/32) | cellular growth and proliferation (F) | |
| cell death (F) | ||
| gene expression--transcription and transactivation (F) | ||
| immune and lymphatic system development and function (F) |
a Numbers in parentheses indicate count of genes with IPA functions/cluster size; LIVR cluster, [5BP, 39NG, 237NG, 266NG] and 208 other genes; PLAC cluster, [104JE, 22JE, 34FL] and 113 other genes; THYM cluster, [383NG, 21PW] and 30 other genes.
b All P-values were < 0.05
Figure 5Interaction network for co-expressed genes in liver and the LIVR cluster showing roles in glycerophospholipid metabolism, protein transport, and signaling. LIVR cluster genes were analyzed using GeneGo MetaCore [32] and its human-specific interaction database. A sub-network was built starting with PLCE1, NGLY1, MX1, TRIP10 and ARF5, which are genes that are predicted to be co-regulated with 237NG and 266NG. Hub genes (IL22RA1, GGA1) predicted by WGCNA were then added to this network. Only interactions known to occur in liver tissue are shown as determined using a liver tissue trace in GeneGO. Majority of these are common to placenta tissue as determined using a placenta tissue trace. Those interactions that are specific to liver only are marked with the letter L. Genes that are expressed as part of the LIVR cluster are indicated with a red circle. A legend explaining the symbols is provided at http://portal.genego.com/legends/legend_6.png.
Inferred biological functions of LSTs.
| Cluster | LSTs | Function Inference |
|---|---|---|
| LIVR | 5BP (ncRNA) | Involved in glycerophospholipid/fatty acid metabolism, cell |
| PLAC | 104JE | Preferential expression in placentome; involved in immune |
| THYM | 383NG | Preferentially expressed in thymus and may play a role in |